Ny CMO i Pharma Equity Groups datterselskab Reponex Pharmaceuticals A/S
14. Juni 2023 02:30 ET
|
Pharma Equity Group A/S
14. juni 2023 Pressemeddelelse Ny CMO i Pharma Equity Groups datterselskab Reponex Pharmaceuticals A/S Vi er glade for at kunne præsentere Dr. Christopher M Burton MD, Ph.d., (født 1973),...
New CMO in Pharma Equity Groups subsidiary Reponex Pharmaceuticals A/S
14. Juni 2023 02:30 ET
|
Pharma Equity Group A/S
14 June 2023 Press Release New CMO in Pharma Equity Groups subsidiary Reponex Pharmaceuticals A/S We are delighted to present Dr Christopher M Burton MD, PhD, (born 1973) an...
Encouraging preliminary data from the first part of a clinical study in pouchitis
08. Juni 2023 11:00 ET
|
Pharma Equity Group A/S
8 June 2023 Announcement no. 34 Encouraging preliminary data from the first part of a clinical study in pouchitis The safety and efficacy...
Settlement - Purchase of shares
02. Juni 2023 05:52 ET
|
Pharma Equity Group A/S
2 June 2023 Announcement no. 33 Inside information Settlement - purchase of shares In connection with completion of Pharma Equity Group A/S' (the "Company") purchase of Reponex...
Managers’ transactions
25. Mai 2023 04:31 ET
|
Pharma Equity Group A/S
May 25,2023 Announcement no. 32 Managers’ transactions Pharma Equity Group A/S has today received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below...
Consolidated interim report 1 January – 31 March 2023
10. Mai 2023 00:49 ET
|
Pharma Equity Group A/S
May 10, 2023 Announcement no. 31 Consolidated interim report 1 January – 31 March 2023 Key points (Q1 2023) The transaction with Reponex Pharmaceuticals A/S On 10 May 2023,...
Forløb af ordinær generalforsamling i Pharma Equity Group A/S (”Selskabet”), den 27. april 2023
27. April 2023 09:31 ET
|
Pharma Equity Group A/S
Pharma Equity Group A/SÅrets meddelelse nr.: 30Dato: 27. april 2023Forløb af ordinær generalforsamling i Pharma Equity Group A/S (”Selskabet”), den 27. april 2023Den 27. april 2023, kl. 14.00 blev der...
Biografi på Professor, overlæge dr. med. Peter Vilmann
24. April 2023 10:33 ET
|
Pharma Equity Group A/S
Pharma Equity Group A/S Årets meddelelse nr.: 29 Dato: 24. april 2023 Biografi på Professor, overlæge dr. med. Peter Vilmann Med henvisning til meddelelse nr. 28 af 21. april 2023 har Pharma...
Professor Peter Vilmann opstiller som kandidat til bestyrelsen på selskabets ordinære generalforsamling og Mette Zacho genopstiller ikke.
21. April 2023 08:21 ET
|
Pharma Equity Group A/S
Professor Peter Vilmann opstiller som kandidat til bestyrelsen på selskabets ordinære generalforsamling og Mette Zacho genopstiller ikke. Pharma Equity Group A/S Selskabsmeddelelse ...
Invitation til HC Andersen Capital event om Pharma Equity Group A/S
20. April 2023 04:26 ET
|
Pharma Equity Group A/S
Invitation til HC Andersen Capital event om Pharma Equity Group A/S Pharma Equity Group – Præsentation af Q1 kvartalsregnskabet 2023 Dato: 11. maj, kl. 14.00. ...